Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cardiotoxicity × Mercaptopurine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 95 Leukemia 58 Burkitt Lymphoma 23 Lymphoma 15 Leukemia, Biphenotypic, Acute 9 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Neoplasm, Residual 5 Leukemia, Promyelocytic, Acute 5 Leukemia, Myeloid, Acute 5 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3 Leukemia, T-Cell 3 Dendritic Cell Sarcoma, Interdigitating 3 Neoplasms 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Large B-Cell, Diffuse 2 Glioblastoma 2 Thrombocytopenia 1 Rare Diseases 1 Psoriasis 1 Philadelphia Chromosome 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Neutropenia 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Mucositis 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1

Interventions

Doxorubicin 15 Echocardiography 13 Exercise 8 Electrocardiography 7 Dexrazoxane 7 Cyclophosphamide 7 Trastuzumab 6 Razoxane 5 Carvedilol 5 Vincristine 4 Filgrastim 4 Radiotherapy 3 Methotrexate 3 Granulocyte Colony-Stimulating Factor 3 Etoposide 3 Docetaxel 3 Cisplatin 3 Atorvastatin 3 salicylhydroxamic acid 2 sacubitril and valsartan sodium hydrate drug combination 2 empagliflozin 2 Tablets 2 Social Determinants of Health 2 Prednisone 2 Magnetic Resonance Spectroscopy 2 Leucovorin 2 Ivabradine 2 High-Intensity Interval Training 2 Chemotherapy, Adjuvant 2 Blood Specimen Collection 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01230983 2013-06-06

T-Cell #4

Children's Oncology Group

Phase 3 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡